NCT07115901 (GI-BOOST) is a NA clinical trial of Lump sum in HIV (Human Immunodeficiency Virus), sponsored by University of California, San Francisco.

Who is sponsoring NCT07115901?

NCT07115901 is sponsored by University of California, San Francisco.

What drugs are being tested in NCT07115901?

Interventions in NCT07115901: Lump sum, Monthly installments, Choice.

What condition does NCT07115901 study?

NCT07115901 studies HIV (Human Immunodeficiency Virus).

Is NCT07115901 still recruiting?

NCT07115901 is currently recruiting now. Last updated 13 March 2026.

Last reviewed 2026-03-13 · How we verify

NCT07115901: GI-BOOST

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Guaranteed Income to Boost HIV Care Continuity and Suppression Post-Jail Release

Recruiting now NA Last updated 13 March 2026

What this trial tests

NA trial testing Lump sum in HIV (Human Immunodeficiency Virus) in 33 participants. Currently enrolling.

Timeline

1 December 2025

Primary endpoint
25 February 2027

25 February 2027

Quick facts

Lead sponsor	University of California, San Francisco
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	33
Start date	1 December 2025
Primary completion	25 February 2027
Estimated completion	25 February 2027
Sites	1 location across United States

Drugs / interventions tested

Lump sum
Monthly installments
Choice

Conditions studied

HIV (Human Immunodeficiency Virus) — all drugs for HIV (Human Immunodeficiency Virus) →

Sponsor

University of California, San Francisco

Who can join

18 and older, any sex, with HIV (Human Immunodeficiency Virus). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to understand the implementation requirements and potential health impacts of a guaranteed income (GI) intervention targeting people living with HIV with criminal legal involvement (PWH-CLI). The main questions it aims to answer are: * How acceptable is a GI intervention, and its intervention components, among PWH-CLI participants and stakeholders? * How feasible is a GI intervention for PWH-CLI? What are the implementation barriers and opportunities for this intervention? * What is the preliminary efficacy of the GI intervention on improving HIV care outcomes for PWH-CLI? Researches will compare study engagement and study outcomes across three randomization arms (A: receive full GI amount as one lump sum payment; B: receive full GI amount split over nine monthly installments; C: participant chooses whether to receive GI as lump sum payment or monthly installments). HIV care outcomes will be compared against a retrospective cohort of PWH-CLI patients as historical controls. Participants will: * Be randomized to receive GI intervention as a lump sum payment or monthly installment (over nine months) or choose their preference. * Complete 3 surveys throughout study follow up to assess experience with the intervention, experience with social services and benefits programs, experience with the criminal legal system, and HIV care outcomes. * Be interviewed by the research team to further understand the experience with the intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for HIV (Human Immunodeficiency Virus)

Currently open trials in the same condition.

NCT07495059 — Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care · NA · recruiting
NCT07336797 — Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy · Phase 2 · recruiting
NCT07062614 — Exploration of the Variability of Exposure to Antiretroviral Treatment in Hair With a View to Validating Its Value as a · recruiting
NCT07150871 — Impact of Covid-19 on Syphilis · active not recruiting
NCT07236905 — Improving Access to HIV Testing for Children in Uganda · NA · recruiting

Other University of California, San Francisco trials

Trials by the same sponsor.

NCT05284773 — Screening for Acute Malnutrition · NA · withdrawn
NCT04634851 — Video Home Visits for Dietary Counselling · NA · not yet recruiting
NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M · Phase 1, PHASE2 · not yet recruiting
NCT07534098 — Intervention for Hearing Health Among Native Americans · NA · not yet recruiting
NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07115901 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
Last refreshed: 13 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07115901.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing